iifl-logo

Jenburkt Pharmaceuticals Ltd Share Price Live

1,359.75
(-2.36%)
Jul 3, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open1,394
  • Day's High1,406
  • 52 Wk High1,406
  • Prev. Close1,392.65
  • Day's Low1,330.3
  • 52 Wk Low 815.8
  • Turnover (lac)36.74
  • P/E19.07
  • Face Value10
  • Book Value389.22
  • EPS71.31
  • Mkt. Cap (Cr.)600.1
  • Div. Yield1.32
View All Historical Data
No Records Found

Jenburkt Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

1,394

Prev. Close

1,392.65

Turnover(Lac.)

36.74

Day's High

1,406

Day's Low

1,330.3

52 Week's High

1,406

52 Week's Low

815.8

Book Value

389.22

Face Value

10

Mkt Cap (₹ Cr.)

600.1

P/E

19.07

EPS

71.31

Divi. Yield

1.32

Jenburkt Pharmaceuticals Ltd Corporate Action

12 May 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

28 May 2024

12:00 AM

AGM

Announcement Date: 28 May, 2024

arrow

28 May 2024

12:00 AM

Dividend

Dividend Amount: 15.3

arrow

Jenburkt Pharmaceuticals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Jenburkt Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

03 Jul, 2025|01:43 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 46.67%

Foreign: 0.00%

Indian: 46.67%

Non-Promoter- 0.12%

Institutions: 0.11%

Non-Institutions: 53.20%

Custodian: 0.00%

Share Price

Jenburkt Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2025Mar-2024Mar-2023Mar-2022

Equity Capital

4.41

4.41

4.41

4.59

Preference Capital

0

0

0

0

Reserves

167.36

140.53

117.98

112.79

Net Worth

171.77

144.94

122.39

117.38

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

123.98

109.29

118.89

114.67

yoy growth (%)

13.43

-8.07

3.67

11

Raw materials

-31.43

-30.09

-33.06

-33.99

As % of sales

25.35

27.53

27.81

29.64

Employee costs

-36.49

-32.37

-36.51

-27.69

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

29.87

21.64

21.13

25.26

Depreciation

-1.89

-2.03

-2.29

-1.5

Tax paid

-7.57

-5.13

-6.26

-8.05

Working capital

-4.98

-5.73

22.53

-2.1

Other operating items

View Cash Flow
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

13.43

-8.07

3.67

11

Op profit growth

37.36

0.49

-16.99

20.62

EBIT growth

37.03

2.08

-15.64

22.94

Net profit growth

35.11

10.98

-13.61

27.42

View Ratios

No Record Found

Jenburkt Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,677.9

944,02,584.412,000.460.957,107.14101.44

Divis Laboratories Ltd

DIVISLAB

6,861.35

82.461,82,147.286670.442,536561.08

Cipla Ltd

CIPLA

1,497.25

25.131,20,934.051,485.41.074,254.47397.41

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,348.4

59.471,13,319.984740.962,385224.33

Dr Reddys Laboratories Ltd

DRREDDY

1,271.75

19.841,06,137.941,200.70.635,546.3345.76

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Jenburkt Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

Ashish U Bhuta

Whole Time Director & CFO

Dilip H Bhuta

Non-Exec. & Independent Dir.

Hina Ravindra Mehta

Independent Director

Sumit Ajaybhai Thakkar

Independent Director

KRISHNAN SUBHARAMAN

Independent Director

PANKAJ ARUN DANTWALA

Company Sec. & Compli. Officer

Ashish R Shah

Registered Office

Nirmala Apartment P B No 37396,

93 Jayprakash Road Andheri(W),

Maharashtra - 400058

Tel: 91-22-66943121/67603603

Website: http://www.jenburkt.com

Email: investor@jenburkt.com

Registrar Office

Office No 56-2,

Pinnacle Busine.Park, Mahakali Caves Road,

Mumbai - 400093

Tel: 91-22-62638200

Website: www.bigshareonline.com

Email: investor@bigshareonline.com

Summary

Jenburkt Pharmaceuticals Ltd, incorporated in 1985, was formed a venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family. The Company is engaged in manufacturing and mark...
Read More

Company FAQs

What is the Jenburkt Pharmaceuticals Ltd share price today?

The Jenburkt Pharmaceuticals Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹1359.75 today.

What is the Market Cap of Jenburkt Pharmaceuticals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Jenburkt Pharmaceuticals Ltd is ₹600.10 Cr. as of 03 Jul ‘25

What is the PE and PB ratio of Jenburkt Pharmaceuticals Ltd?

The PE and PB ratios of Jenburkt Pharmaceuticals Ltd is 19.07 and 3.49 as of 03 Jul ‘25

What is the 52 Week High and Low of Jenburkt Pharmaceuticals Ltd?

The 52-week high/low is the highest and lowest price at which a Jenburkt Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Jenburkt Pharmaceuticals Ltd is ₹815.8 and ₹1406 as of 03 Jul ‘25

What is the CAGR of Jenburkt Pharmaceuticals Ltd?

Jenburkt Pharmaceuticals Ltd's CAGR for 5 Years at 30.81%, 3 Years at 39.70%, 1 Year at 58.22%, 6 Month at 9.12%, 3 Month at 33.91% and 1 Month at 21.74%.

What is the shareholding pattern of Jenburkt Pharmaceuticals Ltd?

The shareholding pattern of Jenburkt Pharmaceuticals Ltd is as follows:
Promoters - 46.68 %
Institutions - 0.12 %
Public - 53.20 %
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.